Description

IntraGly-IM Life Caps for Adult Asthma Care

IntraGly-IM Life Caps is a pack-confirmed inhalation capsule presentation containing three medicine classes used in prescribed adult asthma maintenance therapy: a long-acting beta2-agonist (LABA), a long-acting muscarinic antagonist (LAMA) and an inhaled corticosteroid (ICS). The pack states 1×30 inhalation capsules and the following exact strengths per capsule: indacaterol (as acetate) 150 mcg, glycopyrronium 50 mcg and mometasone furoate 160 mcg.

This product is intended for regular, preventive treatment when prescribed by a qualified healthcare professional. It is not intended to provide immediate relief during a sudden asthma attack. A separate reliever may be needed as prescribed. The capsule is a dose container for inhalation: it is placed into the approved capsule inhaler/device and the powder is breathed through the mouth. Do not swallow the capsule. Follow the approved Indian label, the device instructions supplied with the product and the prescriber’s directions every time.

The three-ingredient combination reflects the LABA/LAMA/ICS class-level approach described in European regulatory information; this does not establish Indian authorization or identical indications for every similar product.

Product Facts

Appropriate Use and Therapeutic Role

In adults whose asthma remains insufficiently controlled despite appropriate controller treatment, a clinician may consider a combination that includes an ICS, LABA and LAMA after reviewing diagnosis, adherence, inhaler technique, exacerbation history and other treatment options. The EMA describes its authorized indacaterol/glycopyrronium bromide/mometasone product as regular maintenance treatment for selected adults whose asthma is not adequately controlled with a LABA plus high-dose ICS and who have had an exacerbation in the previous year. 

That description is class-level educational context, not a claim about this product’s authorization, dose, device or eligibility. Use IntraGly-IM only according to the current approved Indian label and prescriber. It is not a cure or self-treatment for undiagnosed breathlessness.

How the Components Work

Indacaterol is a LABA. It activates beta2 receptors in airway smooth muscle, helping relax the muscle around the airways and keep them open for longer. 

Glycopyrronium is a LAMA. It blocks muscarinic receptors involved in airway-muscle contraction, helping reduce cholinergic bronchoconstriction and support airway opening. 

Mometasone furoate is an ICS. It reduces airway inflammation and inflammatory mediator activity. ICS treatment is a central component of asthma control, but its benefit depends on correct technique, regular use and clinical follow-up. 

These are class explanations, not promises of individual response or product superiority.

Administration and Device Use

Use IntraGly-IM Life Caps exactly as directed by the prescriber and the approved Indian label. The exact inhaler/device supplied or authorized for this product must be used; do not assume that a device designed for another capsule medicine is compatible. If the device supplied with the pack differs from a device described in general educational materials, the approved Indian label and supplied instructions take priority.

In general, a capsule inhaler procedure involves removing one capsule from its blister only immediately before use, placing it in the device’s capsule chamber, preparing the device as instructed, exhaling away from the mouthpiece, inhaling the powder through the mouthpiece and disposing of the empty capsule afterward. The capsule is not a conventional oral capsule: never swallow it, do not place it directly in the mouthpiece and do not store it inside the device. FDA inhalation-capsule instructions emphasize these precautions for capsule-based inhalers. 

A healthcare professional should demonstrate and periodically check technique. Do not change the dose, frequency or device, stop controller treatment, or double a missed dose without label or prescriber instructions. This is not acute-attack treatment; use the prescribed reliever and seek urgent help when directed.

Important Safety Information

Read the current approved Indian package insert before use. Tell the prescriber about allergy to any ingredient, heart disease, high blood pressure, rhythm problems, seizures, thyroid disease, diabetes, glaucoma, urinary-retention or prostate problems, pregnancy, plans for pregnancy, breastfeeding and all prescription, non-prescription or herbal medicines. LABA, LAMA and corticosteroid components can have clinically important effects or interactions in susceptible people.

Seek urgent medical attention for rapidly worsening breathlessness, symptoms that do not respond to the prescribed reliever, chest pain, severe palpitations, fainting, facial or throat swelling, or a sudden worsening immediately after inhalation. Paradoxical bronchospasm can require immediate treatment. Do not use another LABA-containing product unless the prescriber specifically directs it; duplicate bronchodilator therapy may increase risk.

Because this product contains an ICS, rinse the mouth after inhalation if advised. Report oral white patches, worsening cough, visual symptoms or infection. Corticosteroids may affect glucose control; glycopyrronium-type medicines may worsen narrow-angle glaucoma or urinary retention; indacaterol-type medicines may cause tremor, headache, palpitations or changes in potassium or blood glucose. Consult the approved Indian label for the complete profile.

Common or Reported Adverse Effects

Class-level and regulatory information for comparable triple therapy reports respiratory events, nasopharyngitis, upper respiratory tract infection and headache among common or observed adverse effects; other effects can include cough, throat irritation, oral candidiasis, tremor, palpitations, dry mouth or urinary symptoms.  This is educational information, not a complete IntraGly-IM safety profile. Report bothersome or persistent effects to the prescriber and do not discontinue maintenance therapy without advice.

Storage

Store exactly as stated on the approved Indian label and carton. Keep capsules in the original blister until use, protect them from moisture and heat, keep the device dry and keep the medicine away from children. Do not use damaged, wet or expired capsules, transfer them, or use an unapproved inhaler.

PCD Franchise and Distributor Enquiries

Intra Life’s official website describes city-wise PCD opportunities, product supply, marketing materials, training and order support.  Territory, pricing, minimum order, registration, promotion and any monopoly arrangement must be confirmed in writing. No territory, margin, supply volume or business result is guaranteed.

Eligible distributors, wholesalers, chemists and pharmacy businesses may request current availability, licensing, batch documentation and terms. All promotion and supply remain subject to applicable Indian law and licenses.

Third-Party-Manufacturing Enquiries

Qualified pharmaceutical companies may submit an exploratory third-party-manufacturing enquiry. Any discussion depends on technical feasibility, device/formulation compatibility, quality agreements, approvals, pharmacovigilance, batch size, timelines and contract. This page does not confirm availability, approval, capacity, exclusivity, pricing or delivery.

Why Partner with Intra Life

The official website identifies INTRA LIFE PRIVATE LIMITED, lists a Bengaluru corporate house and publishes contacts. It states 46+ years experience, 3500+ pharma products, 2200+ distributors nationwide, 1000+ franchise partners and PAN India presence, and describes quality, marketing, training and order support. 

These are company-published figures, not an independent audit or guarantee of availability, regulatory status, business success or search performance. Conduct due diligence and request current documents before contracting.

Frequently Asked Questions

1. What is IntraGly-IM Life Caps?

It is an inhalation-capsule brand with pack-confirmed indacaterol (as acetate), glycopyrronium and mometasone furoate in a three-class maintenance combination. It is intended for prescribed adult asthma maintenance, not emergency relief.

2. What is the pack size?

The supplied pack fact is 1×30 inhalation capsules.

3. What is the exact composition?

Each capsule contains indacaterol (as acetate) 150 mcg, glycopyrronium 50 mcg and mometasone furoate 160 mcg. These spellings and strengths should be preserved in CMS content and artwork.

4. Can I swallow the capsule?

No. It is for inhalation use only. Place it in the approved prescribed device and inhale the powder as instructed. Never swallow the capsule. [5]

5. Is IntraGly-IM a rescue inhaler?

No. It is a maintenance controller. Sudden symptoms require the separate reliever and emergency plan prescribed by the clinician.

6. Who should use it?

Only adults selected by a qualified prescriber under the current approved Indian label. Do not self-start it for breathlessness.

7. How often should it be used?

Use only the frequency stated on the approved Indian label and prescription. Do not infer a schedule from another indacaterol/glycopyrronium/mometasone product.

8. Can I use any capsule inhaler?

No. Use only the device approved or supplied for this product. Ask a pharmacist or prescriber to demonstrate technique and confirm device compatibility.

9. What are key safety warnings?

Seek urgent help for worsening breathing, severe allergy, chest pain, fainting, severe palpitations or symptoms not relieved by the rescue medicine. Discuss heart, eye, urinary, metabolic, pregnancy and interaction concerns with the prescriber.

10. What side effects may occur?

Possible class-level effects include headache, cough, throat irritation, nasopharyngitis, respiratory infection, oral thrush, dry mouth, tremor or palpitations. See the approved Indian label for the complete list.

11. Should I rinse my mouth?

If directed by the healthcare professional or label, rinse and spit after inhalation to help reduce oral thrush and hoarseness risk. Do not swallow the rinse.

12. What is the price or MRP?

Price, MRP, taxes, availability and batch details can change. Contact Intra Life or an authorized seller for current information; no unverified price is published here.

13. Is PCD franchise availability guaranteed?

No. Territory, monopoly rights, eligibility and terms depend on availability, documents and written agreement. [7]

14. Can wholesalers or distributors enquire?

Yes. Eligible businesses can request current product, licensing, supply and commercial information through the contacts below.

15. Does Intra Life confirm third-party manufacturing for this product?

Not on the official pages reviewed. Submit an exploratory enquiry; feasibility, approvals, capacity, quality agreements and terms require separate confirmation.

Medical and B2B Disclaimer

Medical disclaimer: This page is general product education and CMS copy, not a diagnosis, prescription or individualized medical advice. The pack facts supplied for this page are distinct from class-level educational information and third-party regulatory sources. Always follow the current approved Indian label, carton, device instructions and qualified prescriber. Do not swallow inhalation capsules. Do not use this product as rescue treatment. In an emergency, seek immediate medical care.

B2B disclaimer: PCD, wholesale, distribution and third-party-manufacturing information is an invitation to enquire, not an offer, quotation, guarantee or contract. Territory rights, margins, pricing, minimum order quantities, supply, regulatory documentation and manufacturing feasibility require separate written confirmation from Intra Life Private Limited. No claim is made about cure, superior efficacy, absence of side effects, guaranteed territory or guaranteed Google ranking.

Keywords